RLMD holders · GOLDMAN SACHS GROUP INC 13F · RLMD stock

GOLDMAN SACHS GROUP INC Relmada Therapeutics Inc (RLMD) 13F holding

GOLDMAN SACHS GROUP INC reported 699,039 RLMD shares valued at $4.9M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest RLMD 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the RLMD holders table.

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.